USGI Medical says it raised $19.5 million in new debt and equity financing to fuel international commercial plans and U.S. regulatory efforts for its endoscopic weight-loss device.
California's USGI Medical said it raised $19.5 million in new equity and debt financing designed, in part, to back the final stages of the U.S. approval process for an incision-less endoscopic weight-loss procedure known as POSE.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1yaok0y
Cap comentari:
Publica un comentari a l'entrada